These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2574812)

  • 21. Contraindications to live-viral immunization.
    Legler JD
    J Fam Pract; 1989 Mar; 28(3):333-4. PubMed ID: 2926350
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Communauté française' eradication plan for measles, mumps and rubella].
    Berghmans L; Swennen B; Dachy A; Reginster R; Thieffry P; Drumaux P
    Arch Belg; 1989; 47(1-4):8-10. PubMed ID: 2610579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.
    Babad HR; Nokes DJ; Gay NJ; Miller E; Morgan-Capner P; Anderson RM
    Epidemiol Infect; 1995 Apr; 114(2):319-44. PubMed ID: 7705494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should all children receive two measles vaccinations?
    Li Volti S; Mollica F
    Clin Pediatr (Phila); 1993 Aug; 32(8):509-10. PubMed ID: 8403754
    [No Abstract]   [Full Text] [Related]  

  • 26. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 28. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
    [No Abstract]   [Full Text] [Related]  

  • 29. Mumps incidence in Israel--impact of MMR vaccine.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1990-1991; 18(1):88-93. PubMed ID: 2132885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunizing HIV-positive children.
    Int Nurs Rev; 1989; 36(3):72. PubMed ID: 2737838
    [No Abstract]   [Full Text] [Related]  

  • 31. Recommended childhood immunization schedule. United States--1995.
    Gindler J; Hadler SC; Strebel PM; Watson JC
    Clin Pediatr (Phila); 1995 Feb; 34(2):66-72. PubMed ID: 7729109
    [No Abstract]   [Full Text] [Related]  

  • 32. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'COVER' (cover of vaccination evaluated rapidly): 18.
    Handford SG; White JM; Begg NT
    CDR (Lond Engl Rev); 1991 Jul; 1(8):R90. PubMed ID: 1669786
    [No Abstract]   [Full Text] [Related]  

  • 34. Uptake of measles containing vaccines in the measles, mumps, and rubella second dose catch-up programme in Wales.
    Thomas DR; King J; Evans MR; Salmon RL
    Commun Dis Public Health; 1998 Mar; 1(1):44-7. PubMed ID: 9718839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measles-mumps-rubella vaccination. Objective: 90% vaccinal coverage at 2 years of age in France].
    Lacronique JF; Janvrin MP
    Sante; 1994; 4(3):213. PubMed ID: 7921690
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of seizures after measles-mumps-rubella immunization.
    Griffin MR; Ray WA; Mortimer EA; Fenichel GM; Schaffner W
    Pediatrics; 1991 Nov; 88(5):881-5. PubMed ID: 1945626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new vaccination schedule of the Ministerio de Salud of Chile].
    Vergara J; Advis P
    Rev Chil Pediatr; 1990; 61(2):113-4. PubMed ID: 2136683
    [No Abstract]   [Full Text] [Related]  

  • 40. MMR vaccine: a new initiative.
    Miller C
    Practitioner; 1989 Jan; 233(1461):63-4, 66. PubMed ID: 2798287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.